R. Chandran

Accuracy of a rapid glial fibrillary acidic protein/ubiquitin carboxyl‐terminal hydrolase L1 test for the prediction of intracranial injuries on head computed tomography after mild traumatic brain injury

J. Bazarian, R. Welch, James Chen, 2021, Academic Emergency Medicine.

Comparison of GFAP and UCH-L1 Measurements from Two Prototype Assays: The Abbott i-STAT and ARCHITECT Assays

John K. Yue, G. Manley, D. Okonkwo, 2021, Neurotrauma reports.

Evaluation of Acute Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Plasma Levels in Traumatic Brain Injury Patients with and without Intracranial Lesions

G. Beligere, S. Krieg, P. Biberthaler, 2021, Neurotrauma reports.

Accuracy of a rapid glial fibrillary acidic protein/ubiquitin carboxyl‐terminal hydrolase L1 test for the prediction of intracranial injuries on head computed tomography after mild traumatic brain injury

J. Bazarian, R. Welch, James Chen, 2021, Academic Emergency Medicine.

Plasma biomarker signature associated with improved survival in advanced non-small cell lung cancer patients on linifanib.

V. Devanarayan, S. Ramalingam, P. Ansell, 2015, Lung cancer.

38. Direct and indirect costs associated with the treatment of chronic hepatitis C with chronic kidney disease in India: a cost of illness study

A. Duseja, R. Singhal, P. Tiwari, 2018, Journal of Clinical and Experimental Hepatology.